105 related articles for article (PubMed ID: 11418515)
1. In vitro comparison of the antimycotic activity of a miconazole-HP-beta-cyclodextrin solution with a miconazole surfactant solution.
Piel G; Hayette MP; Pavoni E; Evrard B; Van Hees T; de Hassonville SH; De Mol P; Delattre L
J Antimicrob Chemother; 2001 Jul; 48(1):83-7. PubMed ID: 11418515
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the antimycotic activity of a miconazole HP-beta cyclodextrin solution and a surfactant solution.
Piel G; Hayette MP; Evrard B; Van Hees T; De Mol P; Delattre L
J Pharm Belg; 1999; 54(3):87-8. PubMed ID: 10431477
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the IV pharmacokinetics in sheep of miconazole-cyclodextrin solutions and a micellar solution.
Piel G; Evrard B; Van Hees T; Delattre L
Int J Pharm; 1999 Mar; 180(1):41-5. PubMed ID: 10089290
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity--drug supersaturation, toxicity on TR146 cells and release from a delivery system.
Jacobsen J; Bjerregaard S; Pedersen M
Eur J Pharm Biopharm; 1999 Nov; 48(3):217-24. PubMed ID: 10612032
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activity.
Matsuda H; Ito K; Sato Y; Yoshizawa D; Tanaka M; Taki A; Sumiyoshi H; Utsuki T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1448-52. PubMed ID: 8403092
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydroxypropyl-beta-cyclodextrin on the antimicrobial action of preservatives.
Lehner SJ; Müller BW; Seydel JK
J Pharm Pharmacol; 1994 Mar; 46(3):186-91. PubMed ID: 8027925
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin inclusion complexes of miconazole and econazole--isolation, toxicity on human cells, and confirmation of a new interpretation of the drug supersaturation phenomenon.
Pedersen M; Jacobsen J; Sørensen AM
Drug Dev Ind Pharm; 1999 Apr; 25(4):463-70. PubMed ID: 10194601
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclodextrin on the pharmacology of antifungal oral azoles.
Hostetler JS; Hanson LH; Stevens DA
Antimicrob Agents Chemother; 1992 Feb; 36(2):477-80. PubMed ID: 1605615
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
Yamaguchi H; Hiratani T; Plempel M
Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
[TBL] [Abstract][Full Text] [Related]
10. Hydroxypropyl-beta-cyclodextrin and its combination with hydroxypropyl-methylcellulose increases aqueous solubility of delta9-tetrahydrocannabinol.
Jarho P; Pate DW; Brenneisen R; Järvinen T
Life Sci; 1998; 63(26):PL381-4. PubMed ID: 9877229
[TBL] [Abstract][Full Text] [Related]
11. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben.
Tanaka M; Iwata Y; Kouzuki Y; Taniguchi K; Matsuda H; Arima H; Tsuchiya S
J Pharm Pharmacol; 1995 Nov; 47(11):897-900. PubMed ID: 8708982
[TBL] [Abstract][Full Text] [Related]
12. Prevention of precipitation of phenytoin in an infusion fluid by hydroxypropyl beta-cyclodextrin.
McDonald C; Muzumdar PP
J Clin Pharm Ther; 1998 Jun; 23(3):235-9. PubMed ID: 9831976
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery.
Tenjarla S; Puranajoti P; Kasina R; Mandal T
J Pharm Sci; 1998 Apr; 87(4):425-9. PubMed ID: 9548893
[TBL] [Abstract][Full Text] [Related]
14. Formation and antimicrobial activity of complexes of beta-cyclodextrin and some antimycotic imidazole derivatives.
Van Doorne H; Bosch EH; Lerk CF
Pharm Weekbl Sci; 1988 Apr; 10(2):80-5. PubMed ID: 3393422
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta-cyclodextrin on antimicrobial and photosynthesis inhibiting activity of the cationic surfactant N,N'-bis[4-(4-tert.butylphenoxy)butyl-dimethyl]-1,6-hexanediammonium dibromide.
Král'ová K; Bujdáková H
Pharmazie; 1996 Aug; 51(8):606-8. PubMed ID: 8794475
[No Abstract] [Full Text] [Related]
16. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
[TBL] [Abstract][Full Text] [Related]
17. Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
Brouwer N; Kohen J; Jamie J; Vemulpad S
J Microbiol Methods; 2006 Aug; 66(2):234-41. PubMed ID: 16406566
[TBL] [Abstract][Full Text] [Related]
18. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
19. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
[TBL] [Abstract][Full Text] [Related]
20. New imidazole derivates: in-vitro activity on dermatophytes.
Tullio V; Cuffini AM; Carlone NA; Spignoli G
J Chemother; 1991 Jan; 3 Suppl 1():43-6. PubMed ID: 12041784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
